← Back to Meds

Bimatoprost

Glaucoma · Rx
RxGlaucomaGlaucoma Pga Turquoise cap
Strength0.01% (ophthalmic)
Typical quantity2.5-5 mL bottle (generic available); Durysta is a separate office-placed implant
Cash cost / month Low · ~$0-20
Drug classProstaglandin analog (prostamide)
Mechanism of actionProstamide analog; enhances both trabecular and uveoscleral outflow. Among the most potent IOP-lowering agents.
Indication / reason for useOpen-angle glaucoma and ocular hypertension. Durary biodegradable implant provides months of IOP control from a single intracameral administration.
Usual adult dosing1 drop once daily in the evening.
PreservativeBAK 0.02% (0.01% formulation)
Contact lensesRemove lenses; reinsert after 15 minutes.
Common / important adverse effectsConjunctival hyperemia (more than latanoprost), lash growth, iris and periocular pigmentation, periorbitopathy, macular edema (caution in aphakia/pseudophakia).
Contraindications & cautionsAs for the PGA class.
Pregnancy / lactationAvoid where possible.
Pregnancy category (older labels)No letter category on the current label. From DailyMed labels, checked Nov 2026.
Trade namesLumigan 0.01%, Latisse 0.03% (cosmetic), Durysta (implant)
Practice notesHigher hyperemia rates than latanoprost can limit tolerability; the 0.03% strength was withdrawn from glaucoma use for this reason.
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.

Open in the full tool →